ResMed | RMD - Operating Expenses



ResMed reported $891.42M in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
Ansell USD 358.55M 386.85M Jun/2024
Avita Medical AUD 28.36M 2.44M Dec/2024
Cochlear AUD 897.2M 19.8M Dec/2024
CSL USD 5.72B 173M Dec/2024
Fisher & Paykel Healthcare NZD 778.3M 45.2M Mar/2025
Healius AUD 684.9M 261.2M Dec/2024
Integral Diagnostics AUD 219.16M 66.76M Jun/2024
Mayne Pharma AUD 103.54M 9.39M Jun/2024
Nanosonics AUD 84.9M 42.29M Dec/2024
Polynovo AUD 27.51M 19.08M Jun/2024
Ramsay Health Care AUD 8.35B 258.6M Dec/2024
Regis Healthcare AUD 529.66M 22.28M Dec/2024
ResMed USD 891.42M 26.57M Jun/2025
Sigma Healthcare AUD 1.87B 192.57M Jul/2024
Sonic Healthcare AUD 4.23B 2.14B Dec/2024
Telix Pharmaceuticals AUD 191.9M 130.08M Dec/2024